Dongyu Sheng
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
- Pharmaceutical Science top 10%
-
- Alzheimer's disease research and treatments 7
- Biochemical effects in animals 2
-
- RNA Interference and Gene Delivery 3
- Glycosylation and Glycoproteins Research 1
-
- GDF15 and Related Biomarkers 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Qizhi ZhangKang QianPengzhen WangShuting XuQian GuoYunlong ChengPeng YangJinxu Cao
- Partner nations
- ChinaSouth Korea
In The Last Decade
Dongyu Sheng
15 papers receiving 419 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 119
- Neurology 61
- Pharmaceutical Science 35
- Biological Psychiatry 12
- Physiology 124
Countries citing papers authored by Dongyu Sheng
This map shows the geographic impact of Dongyu Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyu Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyu Sheng more than expected).
Fields of papers citing papers by Dongyu Sheng
This network shows the impact of papers produced by Dongyu Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyu Sheng. The network helps show where Dongyu Sheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongyu Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 25 | |
| 9 | 2022 | 67 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 36 | |
| 12 | 2020 | 73 | |
| 13 | 2020 | 104 | |
| 14 | 2019 | 20 | |
| 15 | 2018 | 43 |
About Dongyu Sheng
Dongyu Sheng is a scholar working on Neurology, Biomaterials and Physiology, having authored 15 papers that have together received 426 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (3 papers), GDF15 and Related Biomarkers (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Biochemical effects in animals (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Biomaterials (119 citations), Neurology (61 citations) and Pharmaceutical Science (35 citations). Dongyu Sheng has collaborated with scholars based in China and South Korea. Frequent co-authors include Qizhi Zhang, Kang Qian, Pengzhen Wang, Shuting Xu, Qian Guo, Yunlong Cheng, Peng Yang, Jinxu Cao, Yixian Li and Liuchang Wang. Their work appears in journals such as ACS Nano, Acta Pharmaceutica Sinica B, Biomaterials, Journal of Controlled Release and Asian Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.